glp 1 drugs and pancreatitis Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk Why Does GLP-1 Cause Pancreatitis?

Wegovy Vision Loss Lawsuit Overview According to legal documents, patients allege that Novo Nordisk, the manufacturer of Wegovy, knew the drug might increase a persons risk of developing serious eye injuries such as nonarteritic anterior ischemic optic neuropathy (NAION) and failed to adequately warn consumers

Why should a drug that makes you think less about food also reduce migraines and gambling compulsions and Parkinsons symptoms

Baeres, G

Expanding Horizons: The profound implications of the FLOW trial for renal outcomes and ongoing research into non-alcoholic steatohepatitis (MASH)

Sitagliptin decreases the LPS-inflammatory response by inhibiting the NF-kB pathway

GLP-1 Therapeutics and Market Context Evolution of the GLP-1 Drug Class GLP-1 receptor agonists mimic the natural GLP-1 hormone